VIVITROL (Naltrexone for Extended Release Injectable Suspension (XR-NTX)) for Opioid Dependent Inmates Released From Prison
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 21 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Apr 2015 New trial record